Sonoma Pharmaceuticals, Inc. (SNOA)
1.13
+0.02
(+1.80%)
USD |
NASDAQ |
Nov 09, 11:26
Sonoma Pharmaceuticals Market Cap : 5.408M for Nov. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 06, 2026 | 5.312M |
| November 05, 2026 | 5.121M |
| November 04, 2026 | 5.312M |
| November 03, 2026 | 5.456M |
| November 02, 2026 | 5.264M |
| October 30, 2026 | 5.264M |
| October 29, 2026 | 5.743M |
| October 28, 2026 | 5.456M |
| October 27, 2026 | 5.504M |
| October 26, 2026 | 5.360M |
| October 23, 2026 | 5.312M |
| October 22, 2026 | 5.504M |
| October 21, 2026 | 5.456M |
| October 20, 2026 | 5.504M |
| October 19, 2026 | 5.360M |
| October 16, 2026 | 5.360M |
| October 15, 2026 | 5.504M |
| October 14, 2026 | 5.552M |
| October 13, 2026 | 5.647M |
| October 12, 2026 | 5.886M |
| October 09, 2026 | 5.886M |
| October 08, 2026 | 5.552M |
| October 07, 2026 | 5.839M |
| October 06, 2026 | 5.886M |
| October 05, 2026 | 5.839M |
| Date | Value |
|---|---|
| October 02, 2026 | 5.934M |
| October 01, 2026 | 5.982M |
| September 30, 2026 | 6.126M |
| September 29, 2026 | 5.958M |
| September 28, 2026 | 6.030M |
| September 25, 2026 | 6.078M |
| September 24, 2026 | 5.958M |
| September 23, 2026 | 5.982M |
| September 22, 2026 | 6.198M |
| September 21, 2026 | 5.982M |
| September 18, 2026 | 6.126M |
| September 17, 2026 | 6.030M |
| September 16, 2026 | 5.886M |
| September 15, 2026 | 6.126M |
| September 14, 2026 | 6.174M |
| September 11, 2026 | 6.246M |
| September 10, 2026 | 6.269M |
| September 09, 2026 | 6.222M |
| September 08, 2026 | 6.365M |
| September 04, 2026 | 6.341M |
| September 03, 2026 | 6.317M |
| September 02, 2026 | 6.174M |
| September 01, 2026 | 6.174M |
| August 31, 2026 | 6.174M |
| August 28, 2026 | 6.269M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.556B |
| Corcept Therapeutics, Inc. | 8.279B |
| Veru, Inc. | 37.17M |
| Johnson & Johnson | 671.73B |
| Eli Lilly & Co. | 1.312T |
Market Cap Related Metrics
| PS Ratio | 0.1155 |
| Price to Book Value | 0.8201 |
| Price | 1.13 |
| Earnings Yield | -107.8% |